337 related articles for article (PubMed ID: 25138021)
1. Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.
Kopec AK; Joshi N; Towery KL; Kassel KM; Sullivan BP; Flick MJ; Luyendyk JP
J Pharmacol Exp Ther; 2014 Nov; 351(2):288-97. PubMed ID: 25138021
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.
Kassel KM; Sullivan BP; Cui W; Copple BL; Luyendyk JP
Am J Pathol; 2012 Oct; 181(4):1287-95. PubMed ID: 22841818
[TBL] [Abstract][Full Text] [Related]
3. Thrombin promotes diet-induced obesity through fibrin-driven inflammation.
Kopec AK; Abrahams SR; Thornton S; Palumbo JS; Mullins ES; Divanovic S; Weiler H; Owens AP; Mackman N; Goss A; van Ryn J; Luyendyk JP; Flick MJ
J Clin Invest; 2017 Aug; 127(8):3152-3166. PubMed ID: 28737512
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
Cheng K; Song Z; Zhang H; Li S; Wang C; Zhang L; Wang T
Med Mol Morphol; 2019 Dec; 52(4):187-197. PubMed ID: 30673851
[TBL] [Abstract][Full Text] [Related]
5. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
[TBL] [Abstract][Full Text] [Related]
6. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
Lee H; Ahn J; Shin SS; Yoon M
Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
[TBL] [Abstract][Full Text] [Related]
7. The polyherbal drug GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits hepatic steatosis and fibroinflammtion in high-fat diet-induced obese mice.
Lim J; Lee H; Ahn J; Kim J; Jang J; Park Y; Jeong B; Yang H; Shin SS; Yoon M
J Ethnopharmacol; 2018 Oct; 225():31-41. PubMed ID: 29958960
[TBL] [Abstract][Full Text] [Related]
8. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.
Yao Y
Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448
[TBL] [Abstract][Full Text] [Related]
9. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
[TBL] [Abstract][Full Text] [Related]
10. Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet.
Kim JH; Suk S; Jang WJ; Lee CH; Kim JE; Park JK; Kweon MH; Kim JH; Lee KW
J Food Sci; 2017 Jul; 82(7):1765-1774. PubMed ID: 28608557
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.
Derdak Z; Villegas KA; Harb R; Wu AM; Sousa A; Wands JR
J Hepatol; 2013 Apr; 58(4):785-91. PubMed ID: 23211317
[TBL] [Abstract][Full Text] [Related]
12. Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice.
Soni NK; Nookaew I; Sandberg AS; Gabrielsson BG
Lipids Health Dis; 2015 Jul; 14():74. PubMed ID: 26193881
[TBL] [Abstract][Full Text] [Related]
13. High fat diet feeding exaggerates perfluorooctanoic acid-induced liver injury in mice via modulating multiple metabolic pathways.
Tan X; Xie G; Sun X; Li Q; Zhong W; Qiao P; Sun X; Jia W; Zhou Z
PLoS One; 2013; 8(4):e61409. PubMed ID: 23626681
[TBL] [Abstract][Full Text] [Related]
14. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways.
Lv Y; Gao X; Luo Y; Fan W; Shen T; Ding C; Yao M; Song S; Yan L
J Nutr Biochem; 2019 Sep; 71():110-121. PubMed ID: 31325892
[TBL] [Abstract][Full Text] [Related]
15. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice.
Hong SA; Jung IR; Choi SE; Hwang Y; Lee SJ; Son Y; Heo YJ; Cui R; Han SJ; Kim HJ; Lee KW; Kang Y
Sci Rep; 2019 Nov; 9(1):17839. PubMed ID: 31780766
[TBL] [Abstract][Full Text] [Related]
16. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
17. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice.
Zhang Z; Chen X; Cui B
Food Funct; 2021 May; 12(10):4504-4518. PubMed ID: 33885128
[TBL] [Abstract][Full Text] [Related]
19. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
[TBL] [Abstract][Full Text] [Related]
20. Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation.
Kim YJ; Choi MS; Park YB; Kim SR; Lee MK; Jung UJ
World J Gastroenterol; 2013 Aug; 19(29):4689-701. PubMed ID: 23922466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
